Skip to content

Adolescent neurobiological predictors of developing psychosis

Adolescent neurobiological predictors of developing psychosis - NeuroImaging of Risk for Psychosis (NIRP)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36521
Enrollment
264
Registered
2010-08-26
Start date
2010-10-20
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis schizophrenia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: This is a follow-up study. Inclusion criteria will be the same as initial intake. General inclusion criteria: - For subjects who initially participated in the DUPS study: Age between 12 and 18 years at initial inclusion - For new subjects: Aged between 12 and 24 years at initial inclusion (to allow us to supplement the DUPS sample) Inclusion criteria for Ultra High Risk for Psychosis (UHR) Group: - No previous psychotic episode for more than one week - No clear organic etiological factor - Voluntary participation (informed consent) - Meets criteria for UHRP (page 19-21 of protocol) Inclusion criteria for controls: -No history of psychiatric disorder (axis 1, DSM-IV) according to diagnostic interview (DISC or SCAN) -No history of psychotic disorder in first or second-degree family members

Exclusion criteria

Exclusion criteria: -Mental retardation (IQ

Design outcomes

Primary

MeasureTime frame
The primary outcome measures are: (1) Cortical thickness, as assessed using a standard anatomical MRI scan (3D-FFE) (2) White matter integrity, as assessed using track-based FA measures from DTI

Secondary

MeasureTime frame
The secondary outcome measures are: (1) Volume of brain structures, as assessed using a standard anatomical MRI scan (3D-FFE) (2) Connectivity of resting state networks, as assessed with resting state fMRI (3) Genotype on candidate risk genes for psychosis

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)